Diabetic Cancer Is On The Rise As Some Diabetes Drugs May Cause Diabetics to Develop Cancer by Texas Diabetic Cancer Lawyer, Diabetic Cancer Death Lawyer, Diabetic Pancreatic Cancer Lawyer and Diabetic Pancreas Cancer Lawyer Jason S. Coomer

  Diabetic Cancer Is On The Rise As Some Diabetes Drugs May Cause Pancreatic Cancer, Bladder Cancer, & other Forms of Deadly Cancer: Persons Taking Januvia, Victoza, Byetta, Janumet, Actos, and other Diabetes Drugs Should Be Aware of Potential Diabetic Cancer Dangers and Consult Their Physician Regarding Potential Pancreas Cancer Risks by Texas Diabetic Cancer Lawyer, Diabetic Cancer Death Lawyer, Diabetic Pancreatic Cancer Lawyer and Diabetic Pancreas Cancer Lawyer Jason S. Coomer

More than 300 million people worldwide suffer from diabetes, including about 30 million Americans.  In 2010, the global prevalence of diabetes was estimated to have reached 285 million and predicted to reach 438 million in 2030. The corresponding figures for North America were 37.4 million in 2010 and 53.2 million by 2030 and in Europe 55.2 million in 2010 and 66.2 million in 2030.  The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018. 

With this huge demand for diabetic treatments have come the aggressive marketing of several diabetic drugs that have been shown to increase a diabetic's risk of cancer including pancreatic cancer, bladder cancer, and other types of cancer. Diabetics and their families should be aware of the potential danger of any diabetic drug.  Further, if a diabetic has been taking a diabetic drug and has been diagnosed with cancer, it is important to report the adverse event to their doctor and the FDA.

 Diabetic Drug Cancer Including Diabetic Pancreatic Cancer and Diabetic Bladder Cancer Needs to Be Reported to Deter Future Misleading Marketing and Distribution of Diabetes Drugs

Pancreatic cancer is the fourth leading cause of cancer death for both men and women and is one of the most deadly of all types of cancer. The diabetes drugs, Januvia, Byetta, Victoza, and Janumet, may cause an increased risk of pancreatic cancer in diabetic patients using the diabetes drugs.   The diabetes drug, Actos, may cause an increased risk of bladder cancer in diabetic patients using this diabetes drug.

If you have lost a loved one from diabetic drug cancer or have suffered acute pancreatitis, hemorrhagic pancreatitis, accute necrotizing pancreatitis, pancreas cancer, or bladder cancer; and have been using a diabetes drug, please report the adverse action to the prescribing medical doctor as soon as possible.  For more diabetic cancer lawsuit, diabetic cancer death lawsuit, or other defect drug cancer lawsuit information, please feel free to contact Diabetic Cancer Lawyer, Diabetic Cancer Death Lawyer, and Defective Drug Cancer Lawyer. 

 

Some Birth Control Medications Can Increase A Woman's Risk of a Heart Attack, Stroke, or Blood Clot Death by Birth Control Blood Clot Death Lawyer

The Multi-Billion Dollar Birth Control Market Includes Several Drug Companies That Are Aggressively Birth Control That Increased A Woman's Risk of a Heart Attack, Stroke, or Blood Clot Death: Women on These Danagerous Birth Control Medications Should be Adequately Warned of the Health Risk by Texas Birth Control Heart Attack Lawyer and Blood Clot Death Lawyer Jason S. Coomer

As the $880 Billion per year global pharmaceutical market continues to expand, many drug companies are looking to make huge profits by selling contraceptives in the rapidly growing multi-billion birth control market.  Many of these drug companies are aggressively marketing contraceptives that increase a woman's risk of suffering a heart attack death, blood clot death, or debilitating stroke.

NuvaRing Is a Once A Month Birth Control That Has Been Linked To An Increased Risk That The Woman Using The Contraceptive Will Suffer a Heart Attack Death, Blood Clot Death, or Debilitating Stroke by Texas NuvaRing Heart Attack and Blood Clot Death Lawyer Jason S. Coomer

The contraceptive, NuvaRing, is a once a month birth control device that has been scientifically linked to an increased risk that the woman using the contraceptive will suffer a heart attack death, blood clot death, or debilitating stroke.  Several NuvaRing Heart Attack Death and Blood Clot Death Lawyers have filed and are currently filing NuvaRing Lawsuits alleging that Merck, the maker of NuvaRing failed to adequately warn women and their doctors about the risks associated with the NuvaRing device.  For more information on NuvaRing Lawsuits, Texas NuvaRing Lawsuits, and International NuvaRing Lawsuits, please  please feel free to contact Texas NuvaRing Heart Attack Death Lawyer and NuvaRing Blood Clot Death Lawyer Jason Coomer or go to the following web page: NuvaRing Heart Attack Death Lawsuit, NuvaRing Blood Clot Death Lawsuit, and NuvaRing Stroke Lawsuit Information.

The Birth Control Medications Yaz, Beyaz, Yasmin, and Ocella Have Been Linked To An Increased Health Risk of Sudden Death, Cardiovascular Problems, Blood Clots, Strokes and Heart Attacks by Texas Pulmonary Embolism Yaz Lawyer, Texas Pulmonary Embolism Yasmin Lawyer, and Texas Pulmonary Embolism Ocella Lawyer Jason S. Coomer

Other hormonal contraceptives including YAZ, Ocella, Beyaz, and Yasmin are also the subject of lawsuits alleging that Bayer HealthCare Pharmaceuticals, Inc. has run false marketing campaigns that were misleading regarding the potential health risks that have been associated with these oral contraceptives.  These lawsuits are also alleging that these drugs cause an increased risk that the woman using the contraceptive will suffer a heart attack death, blood clot death, or debilitating stroke.    

For more information on YAZ, Ocella, Beyaz, Yasmin, and other hormonal contraceptive lawsuits, please feel free to  contact Texas Birth Control Heart Attack, Stroke, and Blood Clot Death Lawyer Jason S. Coomer or go to the following web page: YAZ Heart Attack Death Lawsuit, YAZ Blood Clot Death Lawsuit, and YAZ Stroke Lawsuit Information.

Fatal Blood Clots Can Be Caused By Defective Drugs and Medical Devices by Texas Defective Drug Blood Clot Death Lawyer and Texas Defective Medical Device Fatal Blood Clot Lawyer Jason S. Coomer

Fatal Blood Clots Can Be Caused By Defective Drugs and Defective Medical Devices by Texas Defective Drug Blood Clot Death Lawyer and Texas Defective Medical Device Fatal Blood Clot Lawyer Jason S. Coomer

Fatal blood clots are on the rise as drug companies and medical device manufacturers have aggressively marketed drugs and medical devices that can cause an increased risk of blood clots resulting in heart attacks, strokes, and pulmonary embolisms.  Person using hormonal contraceptives and medical devices that increase their risk of a fatal blood clot should be aware of the potential danger and warning signs of a blood clot.  If you have lost someone from a fatal blood clot or have experienced a serious injury from a blood clot related to a defective drug or medical device, it is important to make sure the adverse event is reported to the prescribing doctor and FDA.

The Birth Control Contraceptive, NuvaRing, Has Been Linked To An Increased Health Risk of Fatal Blood Clots by Texas NuvaRing Blood Clot Lawyer Jason S. Coomer

The hormonal long lasting contraceptive, NuvaRing, is the subject of several lawsuits alleging that the once a month birth contraceptive may cause fatal blood clots and other serious health problems for women that are using this medical device.  For more information on NuvaRing Blood Clot Lawsuits, please go to the following web page: NuvaRing Fatal Blood Clot Lawsuits and NuvaRing Death Lawsuits.

The Birth Control Medications Yaz, Beyaz, Yasmin, and Ocella Have Been Linked To An Increased Health Risk of Sudden Death, Cardiovascular Problems, Blood Clots, Strokes and Heart Attacks by Texas Pulmonary Embolism Yaz Lawyer, Texas Pulmonary Embolism Yasmin Lawyer, and Texas Pulmonary Embolism Ocella Lawyer Jason S. Coomer

YAZ, Ocella, Beyaz, and Yasmin are oral hormonal contraceptives have been aggressively marketed to young women despite research that indicates that the drugs may cause an increased risk of fatal blood clots. For more information on YAZ, Ocella, Beyaz, Yasmin, and other hormonal contraceptive  blood clot lawsuits, please go to the following web page: YAZ Blood Clot Lawsuits, Yasmin Blood Clot Lawsuits, Ocella Blood Clot Lawsuits, Beyaz Blood Clot Lawsuits and Birth Control Blood Clot Death Lawsuits.

Defective Inferior Vena Cava Filters Can Break Apart, Perforate, and Migrate in a Person's Body Causing Fatal Blood Clots and Embolisms by Texas IVC Filter Blood Clot Lawyer Jason S. Coomer

Defective Inferior Vena Cava Filters can migrate, fracture, and break apart inside a person causing fatal blood clots and embolisms.  The FDA recommends that persons with inferior vena cava filters (IVC filters) should contact their doctors regarding removal of the devices.  For more information on IVC Filter Blood Clot Lawsuits, please feel free to go to the following web page: Texas IVC Filter Blood Clot Lawyer and Inferior Vena Cava Filter Failure Embolism Lawyer,

Heart Doctors Concerned Over Pradaxa and Xarelto

 Evidence of the harm caused by the blood thinning drugs Pradaxa and Xarelto continues to grow.  How safe are these drugs and are they really preferable to Wafarin?  Doctors warn that neither of these new drugs has a known antidote for excessive bleeding issues, but Wafarin does.


http://www.huffingtonpost.com/2012/06/14/pradaxa-xarelto-blood-thinner-doctors-heart_n_1595971.html

 "They say that real world use of Pradaxa and Xarelto, which do not require regular blood monitoring or frequent doctor follow-up, raises concerns about the risk of stroke, serious bleeding and blood clots if not taken properly, particularly in patients with poor kidney function.

The nonprofit Institute for Safe Medication Practices estimated last month that 542 reports of deaths associated with Pradaxa were reported to the FDA in 2011, topping all other medicines, including warfarin, with 72 deaths. Adverse event reports on Xarelto were not available."